Manufacturer record

Saitech Medicare Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

7 batches manufactured by Saitech Medicare Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between January 2019 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

7 records linked to Saitech Medicare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
7Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2019 to Mar 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

7
NSQ batches since 2019
6
Products affected
Assay
Most common failure
Mar 2026
Latest alert

Flagged batches per year

2019 · 22022 · 12023 · 12024 · 12025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Dextromethorphan, Phenylephrine and Chlorpheniramine Syrup SML-2643Mfg 2025-12 · Exp 2027-11 The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Phenylephrine HydrochlorideAssay RDTL, ChandigarhCDSCO lab Mar 2026
Ambroxol, Levosalbutamol Guaiphenesin Syrup SML-2465Mfg 2024-03 · Exp 2026-02 AssayAssay DTL/BaddiState lab Sep 2025
Cefpodoxime Proxetil Dispersible Tablets (TROYPOD 200 TABLETS) CT-0778AMfg 2023-12 · Exp 2025-11 DissolutionDissolution RDTL ChandigarhCDSCO lab Mar 2024
Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP (Glimipulse M1 Tablets) SGT- 0624AMfg 2022-12 · Exp 2024-11 Assay of GlimepirideAssay RDTL ChandigarhCDSCO lab Jul 2023
Amoxycillin and Potassium Clavulanate Tablets IP PT-0681AMfg 2021-01 · Exp 2022-12 Dissolution of Amoxycillin and Clavulanic AcidDissolution RDTL GuwahatiState lab May 2022
Amoxycillin And Potassium Clavulanate Tablets I.P. (Clavage-1000) SBPT-4321Mfg 2018-02 · Exp 2019-07 Test for DissolutionDissolution RDTL GuwahatiState lab Jun 2019
Amoxycillin & Potassium Clavulanete Tablets I.P. (Amofive CL 625) SBPT-4686Mfg 2018-05 · Exp 2019-10 Assay of Amoxycillin & DissolutionAssay RDTL GuwahatiState lab Jan 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.